Stroke is defined as an "acute neurologic dysfunction ... Understanding the ischemic cascade has led to the concept of a therapeutic time window for treatment possibilities. Often, there is ...

DiaMedica Therapeutics progresses DM199 for ischemic stroke and preeclampsia, aiming to expand treatment windows. Read why ...

Imperative Care announced that it intends to fund a trial comparing its Zoom stroke system plus best medical treatment to ...

In the Phase III EXPECTS trial, patients experiencing mostly mild posterior circulation ischemic stroke who were ineligible ...

Roche’s RHHBY member company, Genentech, announced the FDA approval of TNKase (tenecteplase), a thrombolytic or ...

Imperative Care, Inc. will fund an independent, randomized clinical trial for the treatment of M2 occlusions in stroke patients.

Imperative Care, Inc. announced it will fund an investigator-initiated, multicenter, randomized controlled clinical trial compari ...

Anaconda Biomed, SL, announced the publication of results of the ANAIS study, which evaluated the safety and performance of the c ...

The study was published online in JAMA Neurology on March 31, 2025.

Please provide your email address to receive an email when new articles are posted on . The odds ratio of a worse modified Rankin score in the asymptomatic hemorrhagic infarction and subarachnoid ...